Subtopic Deep Dive

SOCS3 Negative Regulation of STAT3
Research Guide

What is SOCS3 Negative Regulation of STAT3?

SOCS3 is a feedback inhibitor that negatively regulates STAT3 signaling by inhibiting JAK kinases and promoting their ubiquitin-mediated degradation.

SOCS3 is induced by STAT3 activation in response to cytokines like IL-6, forming a negative feedback loop (Suzuki et al., 2001). It binds to phosphorylated JAKs, blocking STAT3 phosphorylation and recruitment to cytokine receptors (Murray, 2007). Over 10 key papers detail SOCS3's role in cytokine signaling, with foundational work exceeding 4000 citations.

15
Curated Papers
3
Key Challenges

Why It Matters

SOCS3 loss leads to STAT3 hyperactivation, driving chronic inflammation in autoimmunity and cytokine hypersensitivity in cancer (Tanaka et al., 2014; Hirano, 2020). In liver cancer, dysregulated SOCS3-STAT3 axis with NF-κB promotes tumorigenesis (He and Karin, 2010). Therapeutic targeting of SOCS3 restores signaling homeostasis, as shown in IL-6 driven models (Rose-John, 2017).

Key Research Challenges

Mechanisms of SOCS3 Induction

Cytokine-specific induction of SOCS3 via STAT3 remains incompletely mapped across cell types (Tanaka et al., 2014). Variability in feedback timing affects signaling duration (Murray, 2007). Suzuki et al. (2001) identified intestinal roles but broader tissue contexts need clarification.

SOCS3-JAK Degradation Pathways

E3 ligase interactions for JAK ubiquitination by SOCS3 require structural details (Morris et al., 2018). Degradation efficiency varies by cytokine receptor (Hu et al., 2021). Quantitative models of turnover are lacking.

Therapeutic SOCS3 Restoration

Loss-of-function mutations in cancer hinder SOCS3 reactivation strategies (He and Karin, 2010). Delivery challenges limit mimetic efficacy in inflammation (Hirano, 2020). Clinical translation faces hypersensitivity risks (Suzuki et al., 2001).

Essential Papers

1.

IL-6 in Inflammation, Immunity, and Disease

Toshio Tanaka, Masashi Narazaki, T Kishimoto · 2014 · Cold Spring Harbor Perspectives in Biology · 4.7K citations

Interleukin 6 (IL-6), promptly and transiently produced in response to infections and tissue injuries, contributes to host defense through the stimulation of acute phase responses, hematopoiesis, a...

2.

The JAK/STAT signaling pathway: from bench to clinic

Xiaoyi Hu, Jing Li, Maorong Fu et al. · 2021 · Signal Transduction and Targeted Therapy · 2.2K citations

3.

IL-6 in inflammation, autoimmunity and cancer

Toshio Hirano · 2020 · International Immunology · 1.3K citations

Abstract IL-6 is involved both in immune responses and in inflammation, hematopoiesis, bone metabolism and embryonic development. IL-6 plays roles in chronic inflammation (closely related to chroni...

4.

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

Flávia Castro, Ana Patrícia Cardoso, Raquel M. Gonçalves et al. · 2018 · Frontiers in Immunology · 1.2K citations

Interferon-gamma (IFN-γ) is a pleiotropic molecule with associated antiproliferative, pro-apoptotic and antitumor mechanisms. This effector cytokine, often considered as a major effector of immunit...

5.

The JAK-STAT Signaling Pathway: Input and Output Integration

Peter J. Murray · 2007 · The Journal of Immunology · 1.2K citations

Abstract Universal and essential to cytokine receptor signaling, the JAK-STAT pathway is one of the best understood signal transduction cascades. Almost 40 cytokine receptors signal through combina...

6.

NF-κB and STAT3 – key players in liver inflammation and cancer

Guobin He, Michael Karin · 2010 · Cell Research · 1.2K citations

7.

Biology and therapeutic potential of interleukin-10

Margarida Saraiva, Paulo Vieira, Anne O’Garra · 2019 · The Journal of Experimental Medicine · 1.0K citations

The cytokine IL-10 is a key anti-inflammatory mediator ensuring protection of a host from over-exuberant responses to pathogens and microbiota, while playing important roles in other settings as st...

Reading Guide

Foundational Papers

Start with Suzuki et al. (2001) for direct SOCS3-Stat3 knockout evidence in inflammation; Tanaka et al. (2014) for IL-6 context with 4677 citations; Murray (2007) for JAK-STAT integration overview.

Recent Advances

Hu et al. (2021) on therapeutic targeting (2165 citations); Hirano (2020) on cancer implications; Morris et al. (2018) for molecular mechanisms.

Core Methods

SOCS3 knockout mice (Suzuki et al., 2001); co-immunoprecipitation for JAK binding (Morris et al., 2018); phosphotyrosine blotting for STAT3 inhibition (Murray, 2007); ubiquitin assays for degradation.

How PapersFlow Helps You Research SOCS3 Negative Regulation of STAT3

Discover & Search

Research Agent uses searchPapers('SOCS3 STAT3 negative regulation') to retrieve Suzuki et al. (2001) as top hit, then citationGraph reveals 475 citing papers on feedback loops, and findSimilarPapers expands to IL-6 contexts like Tanaka et al. (2014). exaSearch uncovers obscure SOCS3-JAK structures from 250M+ OpenAlex papers.

Analyze & Verify

Analysis Agent applies readPaperContent on Suzuki et al. (2001) to extract SOCS3 knockout inflammation data, then verifyResponse with CoVe cross-checks claims against Murray (2007). runPythonAnalysis simulates STAT3 phosphorylation kinetics using pandas on extracted dose-response data, with GRADE scoring evidence strength for therapeutic claims.

Synthesize & Write

Synthesis Agent detects gaps in SOCS3 cancer therapies via contradiction flagging between Hirano (2020) and He & Karin (2010), generating exportMermaid diagrams of JAK-STAT feedback. Writing Agent uses latexEditText to draft pathways, latexSyncCitations for 10+ refs, and latexCompile for publication-ready reviews.

Use Cases

"Extract signaling rate constants from SOCS3-JAK papers for kinetic model."

Research Agent → searchPapers → Analysis Agent → readPaperContent(Morris et al., 2018) → runPythonAnalysis(NumPy pandas fit decay curves) → matplotlib plot of degradation kinetics.

"Write LaTeX review on SOCS3 feedback in IL-6 signaling."

Synthesis Agent → gap detection → Writing Agent → latexEditText(draft section) → latexSyncCitations(Tanaka et al., 2014; Suzuki et al., 2001) → latexCompile → PDF with STAT3 pathway figure.

"Find GitHub code for SOCS3-STAT3 simulations."

Research Agent → searchPapers('SOCS3 STAT3 model') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(local clone of ODE solver).

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'SOCS3 STAT3 regulation', producing structured report with citationGraph timelines from Suzuki (2001) to Hu et al. (2021). DeepScan applies 7-step CoVe analysis to verify SOCS3 degradation claims in Tanaka et al. (2014). Theorizer generates hypotheses on SOCS3 mimetics from gap detection across IL-6 and cancer papers.

Frequently Asked Questions

What defines SOCS3 negative regulation of STAT3?

SOCS3 inhibits STAT3 by binding JAK kinases, preventing phosphorylation, and promoting E3 ligase-mediated degradation (Suzuki et al., 2001; Murray, 2007).

What are key methods studying SOCS3-STAT3?

Knockout models show inflammation (Suzuki et al., 2001); structural biology details interactions (Morris et al., 2018); kinetic assays quantify feedback (Hu et al., 2021).

What are foundational papers?

Suzuki et al. (2001, 475 citations) proves SOCS3 role in Stat3 intestinal inflammation; Tanaka et al. (2014, 4677 citations) details IL-6-STAT3-SOCS3 axis; Murray (2007, 1157 citations) maps pathway integration.

What open problems exist?

Tissue-specific SOCS3 induction kinetics; scalable mimetic design for cancer; quantitative models integrating PIAS3 sumoylation (He and Karin, 2010; Hirano, 2020).

Research Cytokine Signaling Pathways and Interactions with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching SOCS3 Negative Regulation of STAT3 with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers